🇺🇸 FDA
Patent

US 12138233

Methods of treating idiopathic hypersomnia

granted A61KA61K31/19A61K9/08

Quick answer

US patent 12138233 (Methods of treating idiopathic hypersomnia) held by Jazz Pharmaceuticals Ireland Limited expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jazz Pharmaceuticals Ireland Limited
Grant date
Tue Nov 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/19, A61K9/08, A61P, A61P25/00